Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

2.830

-0.030 (-1.05%)

At close: Mar 13, 2026, 4:00 PM EDT

2.940

+0.110 (3.89%)

After-hours: Mar 13, 2026, 6:51 PM EDT

Anixa Biosciences Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	-	-	-	0.21	-	0.51
Selling, General & Admin	6.55	6.63	7.44	6.29	7.17	7.07
Research & Development	4.95	5.07	6.4	4.77	6.7	6.19
Other Operating Expenses	-	-	-	0.16	-	0.39
Total Operating Expenses	11.5	11.7	13.83	11.22	13.88	13.65
Operating Income	-11.5	-11.7	-13.83	-11.01	-13.88	-13.14
Interest Income	0.73	0.67	1.13	1.08	0.1	0
Other Non-Operating Income (Expense)	-	-	-	-	-	0.01
Total Non-Operating Income (Expense)	0.73	0.67	1.13	1.08	0.1	0.01
Pretax Income	-10.77	-11.03	-12.7	-9.93	-13.77	-13.13
Net Income	-10.66	-10.93	-12.55	-9.81	-13.6	-12.95
Minority Interest in Earnings	0.11	0.1	0.14	0.12	0.18	0.17
Net Income to Common	-10.66	-10.93	-12.55	-9.81	-13.6	-12.95
Shares Outstanding (Basic)	33	33	32	31	30	29
Shares Outstanding (Diluted)	33	33	32	31	30	29
Shares Change (YoY)	6.71%	3.50%	2.96%	1.99%	6.28%	28.57%
EPS (Basic)	-0.32	-0.33	-0.39	-0.32	-0.45	-0.45
EPS (Diluted)	-0.32	-0.33	-0.39	-0.32	-0.45	-0.45
Free Cash Flow	-7.47	-7.17	-7.34	-6.21	-6.49	-4.94
Free Cash Flow Per Share	-	-	-0.23	-0.20	-0.21	-0.17
Gross Margin	-	-	-	100.00%	-	100.00%
Operating Margin	-	-	-	-5243.33%	-	-2565.63%
Profit Margin	-	-	-	-4728.57%	-	-2564.06%
FCF Margin	-	-	-	-2956.67%	-	-964.45%
EBITDA	-11	-11.67	-13.79	-10.97	-13.83	-13.08
EBITDA Margin	-	-	-	-5221.43%	-	-2553.91%
EBIT	-11.5	-11.7	-13.83	-11.01	-13.88	-13.14
EBIT Margin	-	-	-	-5243.33%	-	-2565.63%

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q